(Q37795307)
Statements
Third-line sorafenib after sequential therapy with sunitinib and mTOR inhibitors in metastatic renal cell carcinoma (English)
Ciro Imbimbo
Sabino De Placido
Giuseppe Di Lorenzo
Piera Federico
Michele Milella
Cinzia Ortega
Carmine D'Aniello
Alessandra Felici
Enzo Maria Ruggeri
Giovannella Palmieri
24 September 2010